Critical analysis of cystic echinococcosis control programs and praziquantel use in South America, Send correspondence to Edmundo Larrieu, email: elarrieu salud. Control programs in South America were originally modeled after programs developed in insular territories, such as Tasmania and New Zealand. The advent and proven effectiveness of praziquantel, plus the experience of insular models, produced high expectations for rapid advances; however, after 30 years of praziquantel use, no endemic area in South America has obtained eradication. In fact, only modest gains in CE control have been made and impact on prevalence among humans has been slight.
|Published (Last):||17 August 2014|
|PDF File Size:||9.53 Mb|
|ePub File Size:||1.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI: The objetive of this study was to estimate the echinococcosis prevalence in dogs in the XII Region.
In the three Provinces in which the Hydatidosis Control Proyect is developed a random sample of dogs was taken. In the field the arecoline test was used and, addicionally, a questionary was appliedto the dog owners. Esperanza Province and one in Tierra del Fuego. View PDF. Save to Library. Create Alert. Launch Research Feed. Share This Paper. Citations Publications citing this paper.
Estimación de la prevalencia de equinococosis canina en la XII Región, Chile, 2002
The objetive of this study was to estimate the echinococcosis prevalence in dogs in the XII Region. In the three Provinces in which the Hydatidosis Control Proyect is developed a random sample of dogs was taken. In the field the arecoline test was used and, addicionally, a questionary was applied to the dog owners. Esperanza Province and one in Tierra del Fuego. It can be concluded that the prevalence of canine echinococcosis in the XII Region remained at a low level since It is important to increase the efforts and adopt new strategies in order to erradicate the disease from the Region.
This report summarizes the outcomes of a meeting on cystic echinococcosis CE in animals and humans in Chile held in Santiago, Chile, between the 21st and 22nd of January Current and future CE control activities were discussed. It was noted that the EG95 vaccine was being implemented for the first time in pilot control programmes, with the vaccine scheduled during in two different regions in the South of Chile. In relation to use of the vaccine, the need was highlighted for acquiring good quality data, based on CE findings at slaughterhouse, previous to initiation of vaccination so as to enable correct assessment of the efficacy of the vaccine in the following years. Cystic echinococcosis CE remains as an important health problem affecting animals and humans in Chile [ 1 , 2 ].